237 related articles for article (PubMed ID: 14730505)
1. Vitamin D receptor and analogs.
Dusso AS; Thadhani R; Slatopolsky E
Semin Nephrol; 2004 Jan; 24(1):10-6. PubMed ID: 14730505
[TBL] [Abstract][Full Text] [Related]
2. The induction of C/EBPβ contributes to vitamin D inhibition of ADAM17 expression and parathyroid hyperplasia in kidney disease.
Arcidiacono MV; Yang J; Fernandez E; Dusso A
Nephrol Dial Transplant; 2015 Mar; 30(3):423-33. PubMed ID: 25294851
[TBL] [Abstract][Full Text] [Related]
3. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
4. Local NF-κB Activation Promotes Parathyroid Hormone Synthesis and Secretion in Uremic Patients.
Mao J; Wang M; Ni L; Gong W; Jiang X; Zhang Q; Zhang M; Wen D; Chen J
Endocrinology; 2021 Jul; 162(7):. PubMed ID: 33912936
[TBL] [Abstract][Full Text] [Related]
5. Parathyroid-specific epidermal growth factor-receptor inactivation prevents uremia-induced parathyroid hyperplasia in mice.
Arcidiacono MV; Yang J; Fernandez E; Dusso A
Nephrol Dial Transplant; 2015 Mar; 30(3):434-40. PubMed ID: 25324357
[TBL] [Abstract][Full Text] [Related]
6. EGFR activation increases parathyroid hyperplasia and calcitriol resistance in kidney disease.
Arcidiacono MV; Sato T; Alvarez-Hernandez D; Yang J; Tokumoto M; Gonzalez-Suarez I; Lu Y; Tominaga Y; Cannata-Andia J; Slatopolsky E; Dusso AS
J Am Soc Nephrol; 2008 Feb; 19(2):310-20. PubMed ID: 18216322
[TBL] [Abstract][Full Text] [Related]
7. Vitamin D receptor ligand therapy in chronic kidney disease.
Gonzalez E
Clin Nephrol; 2008 Oct; 70(4):271-83. PubMed ID: 18826852
[TBL] [Abstract][Full Text] [Related]
8. Vitamin D receptor agonist VS-105 directly modulates parathyroid hormone expression in human parathyroid cells and in 5/6 nephrectomized rats.
Sawada K; Wu-Wong JR; Chen YW; Wessale JL; Kanai G; Kakuta T; Fukagawa M
J Steroid Biochem Mol Biol; 2017 Mar; 167():48-54. PubMed ID: 27989797
[TBL] [Abstract][Full Text] [Related]
9. Vitamin D and the parathyroid.
Beckerman P; Silver J
Am J Med Sci; 1999 Jun; 317(6):363-9. PubMed ID: 10372835
[TBL] [Abstract][Full Text] [Related]
10. [Vitamin D metabolism and current options for therapeutic activation of vitamin D receptor in patients with chronic kidney disease or renal failure].
Dusilová Sulková S
Vnitr Lek; 2012 Nov; 58(11):839-49. PubMed ID: 23256830
[TBL] [Abstract][Full Text] [Related]
11. NF-κB activation contributes to parathyroid cell proliferation in chronic kidney disease.
Kan S; Zhang W; Mao J; Wang M; Ni L; Zhang M; Zhang Q; Chen J
J Nephrol; 2018 Dec; 31(6):941-951. PubMed ID: 30171599
[TBL] [Abstract][Full Text] [Related]
12. Exclusive underexpression of vitamin D receptor exon 1f transcripts in tumors of primary hyperparathyroidism.
Correa P; Akerstrom G; Westin G
Eur J Endocrinol; 2002 Nov; 147(5):671-5. PubMed ID: 12444900
[TBL] [Abstract][Full Text] [Related]
13. Effects of 19-nor-1,25(OH)2D2, a new analogue of calcitriol, on secondary hyperparathyroidism in uremic rats.
Slatopolsky E; Finch J; Ritter C; Takahashi F
Am J Kidney Dis; 1998 Oct; 32(2 Suppl 2):S40-7. PubMed ID: 9808142
[TBL] [Abstract][Full Text] [Related]
14. Reduced parathyroid vitamin D receptor messenger ribonucleic acid levels in primary and secondary hyperparathyroidism.
Carling T; Rastad J; Szabó E; Westin G; Akerström G
J Clin Endocrinol Metab; 2000 May; 85(5):2000-3. PubMed ID: 10843188
[TBL] [Abstract][Full Text] [Related]
15. The roles of calcium and 1,25-dihydroxyvitamin D3 in the regulation of vitamin D receptor expression by rat parathyroid glands.
Brown AJ; Zhong M; Finch J; Ritter C; Slatopolsky E
Endocrinology; 1995 Apr; 136(4):1419-25. PubMed ID: 7895652
[TBL] [Abstract][Full Text] [Related]
16. Vitamin D analogues for the management of secondary hyperparathyroidism.
Martin KJ; González EA
Am J Kidney Dis; 2001 Nov; 38(5 Suppl 5):S34-40. PubMed ID: 11689385
[TBL] [Abstract][Full Text] [Related]
17. Direct maxacalcitol injection into hyperplastic parathyroids improves skeletal changes in secondary hyperparathyroidism.
Shiizaki K; Hatamura I; Negi S; Sakaguchi T; Saji F; Kunimoto K; Okamoto M; Imazeki I; Muragaki Y; Akizawa T
Kidney Int; 2006 Aug; 70(3):486-95. PubMed ID: 16788697
[TBL] [Abstract][Full Text] [Related]
18. Persistent downregulation of calcium-sensing receptor mRNA in rat parathyroids when severe secondary hyperparathyroidism is reversed by an isogenic kidney transplantation.
Lewin E; Garfia B; Recio FL; Rodriguez M; Olgaard K
J Am Soc Nephrol; 2002 Aug; 13(8):2110-6. PubMed ID: 12138143
[TBL] [Abstract][Full Text] [Related]
19. Parathyroid Cell Proliferation in Secondary Hyperparathyroidism of Chronic Kidney Disease.
Naveh-Many T; Volovelsky O
Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32570711
[TBL] [Abstract][Full Text] [Related]
20. Development of parathyroid gland hyperplasia without uremia: role of dietary calcium and phosphate.
Canalejo A; Canalejo R; Rodriguez ME; Martinez-Moreno JM; Felsenfeld AJ; Rodríguez M; Almaden Y
Nephrol Dial Transplant; 2010 Apr; 25(4):1087-97. PubMed ID: 19934096
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]